CEO Mark J Foley sold $2.4M of Revance Therapeutics, Inc.

Sold$2,433,725

$34.55Price

70,447Shares

−6%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Mon, May 15. Filed Tue, May 16, 4:29 PM ET, after the close. Not investment advice.